Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00139295 | Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee | PHASE3 | COMPLETED | - | — | — | Oct 1, 2004 | Sep 1, 2007 | Feb 5, 2014 | 24 | United States, Canada +3 |
| Name | Type | Description |
|---|---|---|
| Hylastan | DEVICE | - |
Inclusion Criteria: * Diagnosed with OA of the knee * Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications Exclusion Criteria: * Prior or concomitant treatments that would impede measurement of safety and efficacy